Aimee Bell, NP
Family · Fort Wayne, INNPI 1841668472
Payments from drug & device makers
Across 23 payments — averaging $46.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insulet Corporation$376
- Abbott$312
- Tactile Systems Technology Inc$194
- Bayer$122
- Baxter Healthcare$20
- Welch Allyn$20
- plus $28 from 2 others
What the payments were for
- Food & beverage$1,03296%
- Other$404%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insulet Corporation | 6 | $376 |
| Abbott | 4 | $312 |
| Tactile Systems Technology Inc | 8 | $194 |
| Bayer | 1 | $122 |
| Baxter Healthcare | 1 | $20 |
| Welch Allyn | 1 | $20 |
| Gilead | 1 | $14 |
| KCI USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnipod$338
- Kerendia$122
- FREESTYLE LIBRE 3$121
- FreeStyle Libre 2$109
How this compares
$1,073 in reported general payments places this provider in the 65th percentile of 4,392 family providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 300 | $533,059 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 161 | $233,528 |
| JardianceEmpagliflozin | 185 | $215,370 |
| EliquisApixaban | 149 | $149,955 |
| MounjaroTirzepatide | 57 | $98,091 |
| RybelsusSemaglutide | 31 | $76,015 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 48 | $69,341 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 33 | $44,776 |
| XareltoRivaroxaban | 43 | $41,658 |
| GemtesaVibegron | 41 | $39,789 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 31 | $29,692 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 22 | $20,630 |
| Spiriva RespimatTiotropium Bromide | 15 | $19,751 |
| Breo ElliptaFluticasone/Vilanterol | 33 | $18,810 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 105 | $18,421 |
Paid to pharmacies, not to this prescriber.
Other family in Fort Wayne
- Justin BrownFort Wayne$142K
- Tracy JohnsonFort Wayne$68K
- Grant BlauveltFort Wayne$28K
- Benjamin GiarmoFort Wayne$21K
- Katarzyna SedlaczekFort Wayne$20K
- Brandy DantzerFort Wayne$18K
- Catherine RobertsFort Wayne$13K
- Adam ZuberFort Wayne$13K
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.